|
⚲
|
| Keyboard |
| Mhatre Rohin
✚
|
|
|---|---|
| CIK # | 0001798735 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001798735] | |
| 4 | [0001798735] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mhatre Rohin | |
| Parabilis Medicines Inc | |
| Repligen Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2025-05-15 | Grant | 1,800 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2025-05-15 | Grant | 973 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2024-05-16 | Grant | 701 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2024-05-16 | Grant | 1,376 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2023-05-18 | Grant | 686 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2023-05-18 | Grant | 1,487 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2022-05-26 | Grant | 2,920 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2022-05-26 | Grant | 1,202 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2021-05-13 | Grant | 457 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2021-05-13 | Grant | 1,151 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2020-03-01 | Grant | 3,452 | $0.00 |